top of page

Global CVCT Forum

logo v3.png
CVCT 2023 multistakeholders

CROs-AROs

Academics

Principal Investigators

Patients-

Advocacy

Regulatory

(FDA, EMA)

Industry R&D

Clinicians

Lawyers

Major journal editors

Statisticians-Methodologists

Payers-HTAs

MedTech-BioTech

Investors

CVCT Chairpersons

courbes_edited_edited_edited.jpg
Faiez Zannad, Founder and Chairman of CVCT

Faiez Zannad

Founder & chairman

UNIVERSITE DE LORRAINE, NANCY, FRA

  • Twitter
  • LinkedIn

Bertram Pitt

Co-chairman

UNIVERSITY OF MICHIGAN, ANN ARBOR, USA

  • LinkedIn
courbes_edited_edited_edited.jpg
Bertram Pitt, CVCT

NEW AT CVCT 2024

WINE & CHEESE POSTER PRESENTATION SESSION

Poster presentations of :

 → Rationale, design and main features of planned or ongoing trials 

 → Main results of early-stage trials 

 → Results of secondary analyses of major phase 3 trials with primary main results recently published or presented in major meetings late breakers or hot line sessions.

 → Results of new meta-analyses​

​

DISCOVER HERE

CLINICAL TRIAL SCIENCE
AT ITS BEST

EXPAND OVER
INCLUDING
INVOLVING

03

40

400

DAYS
SESSIONS
SPEAKERS
bottom of page